20 Hrs
Source:
المشهد العربي
J&J Shares Hit New High
Shares of the American company Johnson & Johnson achieved an unprecedented record closing, after the U.S. Food and Drug Administration (FDA) granted regulatory approval for the use of its robotic surgical system, "O-Tava." The stock jumped 3.33% to reach $271.11, marking a new high in Wall Street trading. This boost reflects investor optimism about the growth of the company’s medical device sector and its competitive resilience. Since the beginning of the year, the stock has increased by 31%, outperforming the S&P 500 index significantly, despite the economic and geopolitical challenges.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)